[Prevention of anaphylaxis & serum disease in tetanus prophylaxis].
D000707:Anaphylaxis; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control*; D013742:Tetanus / Q000517:prevention & control*
D006634:Histamine H1 Antagonists
ALLERGY/prevention and control; ANTIHISTAMINICS/therapeutic use; TETANUS/prevention and control
Zur Verhinderung von Anaphylaxie und Serumkrankheit in der Tetanusprophylaxe.